Foxp3 is critical for human natural CD4+CD25+ regulatory T cells to suppress alloimmune response

Transplant Immunology

Volumn 26, Issue 2-3, 2012, Pages 71-80

  Sun, Lei ^a   Wu, Jingjing ^b   Yi, Shounan ^b,c  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Alloimmune response; Foxp3; Phenotype; SiRNA; Suppressive function

Indexed keywords

SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXP3;

ALLOIMMUNITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOTOXICITY; MIXED LYMPHOCYTE REACTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; CELL PROLIFERATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; MALE; MICE; RNA, SMALL INTERFERING; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 84856548581     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.10.005     Document Type: Article

References (43)

1. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000, 101:455-458.
2. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
3. + suppressor T cells. Immunol Rev 2001, 182:58-67.
4. + cells: a naturally occurring population of regulatory T cells. Blood 2001, 98:2736-2744.
5. Lin W., Haribhai D., Relland L.M., Truong N., Carlson M.R., Williams C.B., et al. Regulatory T cells development in the absence of functional Foxp3. Nat Immunol 2007, 8:359-368.
6. Zheng Y., Manzotti C.N., Burke F., Hong S., Youn J. Acquisition of suppressive function by activated human CD4+CD25- T cells is associated with the expression of CTLA-4 not Foxp3. J Immunol 2008, 181:1683-1691.
7. Antons A.K., Wang R., Oswald-Richter K., Tseng M., Arendt C.W., Kalams S.A., et al. Naïve precursors of human regulatory T cells require Foxp3 for suppression and are susceptible to HIV infection. J Immunol 2008, 74:764-773.
8. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
9. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003, 4:337-342.
10. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22:329-341.
11. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001, 27:68-73.
12. Bebett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27:20-21.
13. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001, 27:18-20.
14. - T cells by T-cell receptor stimulation is transforming growth factor-ß-dependent but does not confer a regulatory phenotype. Blood 2007, 15:2983-2990.
15. Allan S.E., Passerini L., Bacchetta R., Crellin N., Dai M., Orban P.C., et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 2005, 115:3276-3284.
16. Roncador G., Brown P.J., Maestre L., Hue S., Martínez-Torrecuadrada J.L., Ling K.L., et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 2005, 35:1681-1691.
17. Maggi E., Cosmi L., Liotta F., Romagnani P., Romagnani S., Annunziato F. Thymic regulatory T cells. Autoimmun Rev 2005, 4:579-586.
18. Xia G., Shah M., Luo X. Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells. Transl Res 2009, 153:60-70.
19. Dykxhoorn D.M., Pallister D., Lieberman J. The silent treatment: siRNAs as small molecule drugs. Gene Ther 2006, 13:541-552.
20. Barik S. Silence of the transcripts: RNA interference in medicine. J Mol Med 2005, 83:764-773.
21. De Fougerolles A., Vornlocher H.P., Maraganore J., Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discovery 2007, 6:443-453.
22. Peer D., Zhu P., Carman C.V., Lieberman J., Shimaoka M. Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc Natl Acad Sci U S A 2007, 104:4095-4100.
23. + regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses. Transplantation 2008, 85:1841-1848.
24. Miyara M., Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 2007, 13:108-116.
25. Kitazawa Y., Fujino M., Wang Q., Kimura H., Azuma M., Kubo M., et al. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell responses. Transplantation 2007, 83:774-782.
26. Huang C.T., Workman C.J., Flies D., Pan X., Marson A.L., Zhou G., et al. Role of LAG-3 in regulatory T cells. Immunity 2004, 21:503-513.
27. Baecher-Allan C., Wolf E., Hafler D.A. MHC class II expression identifies functionally distinct regulatory T cells. J Immunol 2006, 176:4622-4631.
28. Pandiyan P., Zheng L., Ishihara S., Reed J., Lenardo M.J. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 2007, 8:1353-1362.
29. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of Foxp3. Nat Genet 2001, 27:20-21.
30. Le Bras S., Geha R.S. IPEX and the role of Foxp3 in the development and function of human Tregs. J Clin Invest 2006, 116:1473-1475.
31. Torgerson T.R., Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 2007, 120:744-750.
32. Pillai V., Ortega S.B., Wang C.K., Karandikar N.J. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 2007, 123:18-29.
33. + T cells. Eur J Immunol 2007, 37:129-138.
34. Allan Sarah E., Laura Passerini, Rosa Bacchetta, Crellin N., Dai M., Orban P.C., et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 2005, 115:3276-3284. [PubMed: 16211090].
35. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., et al. Foxp3 controls regulatory T cell function through cooperation with NFAT. Cell 2006, 126:375-387.
36. Bettelli E., Dastrange M., Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A 2005, 102:5138-5143.
37. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007, 446:685-689.
38. Ziegler S.F. FOXP3: not just for regulatory T cells anymore. Eur J Immunol 2007, 37:21-23.
39. Chauhan S.K., Saban D.R., Lee H.K., Dana R. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol 2009, 182:148-153.
40. McMurchy A.N., Bushell A., Levings M., Wood K.J. Moving to tolerance: clinical application of T regulatory cells. Semin Immunol May 28, 2011, [Epub ahead of print] [PubMed: 21620722].
41. Wood K.J., Bushell A., Jones N.D. Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells. Immunol Rev 2011, 241:119-132.
42. Floess S., Freyer J., Siewert C., Baron U., Olek S., Polansky J., et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007, 5:169-178.
43. Josefowicz S.Z., Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009, 30:616-625.